Trial Details

TERMINATED
Basic Information
Clinical ID c764
Identifier NCT03341962
Trial Title Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: IMU-838|DRUG: Placebo
Participant Information
Sponsor Immunic AG
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-03-15
Primary Completion Date 2022-11-16
Completion Date 2022-11-16